|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Non-trade accounts receivable, net | |||||||||||||||||||
| Non-trade accounts receivable - related parties | |||||||||||||||||||
| Inventories, net | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Investment held in Trust Account | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Investment held in Trust Account | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Restricted cash held in trust account | |||||||||||||||||||
| Property, plant and equipment, net | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Deferred transaction costs | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Other noncurrent assets | |||||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||||
| Due to affiliates | |||||||||||||||||||
| Due to Affiliates | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total due to affiliates | |||||||||||||||||||
| Franchise tax payable | |||||||||||||||||||
| Due to shareholders for redemption of Common Stock | |||||||||||||||||||
| Bank overdraft | |||||||||||||||||||
| Income taxes payable | |||||||||||||||||||
| Excise tax payable and interest and penalties | |||||||||||||||||||
| Due to stockholders for redemption of Common Stock | |||||||||||||||||||
| Excise tax payable | |||||||||||||||||||
| Convertible promissory notes – related party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total convertible promissory notes – related party | |||||||||||||||||||
| Working capital loans – related party | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total working capital loans – related party | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accounts payable - related parties | |||||||||||||||||||
| Non-trade accounts payable | |||||||||||||||||||
| Non-trade accounts payable - related parties | |||||||||||||||||||
| Short term debt | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Total short term debt | |||||||||||||||||||
| Short term debt - related parties | |||||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||||
| Convertible promissory notes | |||||||||||||||||||
| July investment agreement derivative | |||||||||||||||||||
| CPU Share Allocation Obligation | |||||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||||||
| Long term debt | |||||||||||||||||||
| Long term debt -related parties | |||||||||||||||||||
| Convertible debentures | |||||||||||||||||||
| Other noncurrent liabilities | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| Common Stock subject to possible redemption, $0.0001 par value, 564,337 shares at redemption value of $11.34 per share at December 31, 2025 and 1,082,789 shares at redemption value of $11.22 per share at December 31, 2024, respectively | |||||||||||||||||||
| Stockholders’ Deficit | |||||||||||||||||||
| Common stock $0.0001 par value, 1,500,000,000 shares authorized, 621,790,646 and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Equity-classified CPU share allocation | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Convertible preferred units (Note 13 - Equity) | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||||||||||
| Total stockholders’ deficit | |||||||||||||||||||
| Noncontrolling interest | |||||||||||||||||||
| Total deficit | |||||||||||||||||||
| Total liabilities and stockholders’ deficit | |||||||||||||||||||
Loading...
